abstract |
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts and prodrugs thereof, wherein R 1 , R 2 and R 3 are as defined in the specification. The compounds are neurotrophin (eg, nerve growth factor) receptor agonists. |